Hermetica Superfood Encyclopedia
The Short Answer
Cryptoxanthin is a xanthophyll carotenoid, with beta-cryptoxanthin being the primary bioactive form, functioning as both an antioxidant and a provitamin A compound. It neutralizes reactive oxygen species (ROS) via its conjugated polyene chain and is converted to retinol in the intestinal mucosa by beta-carotene 15,15'-monooxygenase (BCMO1).
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordcryptoxanthin benefits
Synergy Pairings5
Cryptoxanthin — botanical close-up
Health Benefits
Origin & History
Natural habitat
Cryptoxanthin is an oxygenated carotenoid with the molecular formula C₄₀H₅₆O, naturally occurring as an orange-yellow tetraterpene pigment. It is primarily isolated from fruits such as papaya, peaches, oranges, and Satsuma mandarin oranges, as well as from some leafy green vegetables. This fat-soluble compound functions as a precursor to vitamin A in human metabolism.
“The research dossier does not provide information on historical use in traditional medicine systems or the duration of traditional applications. No traditional or cultural context for cryptoxanthin use is documented in the available sources.”Traditional Medicine
Scientific Research
The available research dossier does not contain any human clinical trials, randomized controlled trials, meta-analyses, or PubMed PMIDs evaluating cryptoxanthin's clinical efficacy. While sources indicate cryptoxanthin is being studied for potential benefits in eye health and immune function, no detailed clinical study data, sample sizes, or outcomes are available.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges, standardized extract forms, or dosing protocols for cryptoxanthin supplementation are available in the current research. The compound is fat-soluble and best absorbed in the presence of dietary fats. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Cryptoxanthin is a xanthophyll carotenoid (oxygenated carotenoid) and provitamin A compound, not a macronutrient source itself. Key biochemical profile: Molecular formula C40H56O, molecular weight 552.87 g/mol. Contains one hydroxyl group distinguishing it from beta-carotene. Provitamin A activity: approximately 50% of beta-carotene's provitamin A potency; 1 molecule yields approximately 0.5 retinol equivalents upon enzymatic cleavage by beta-carotene 15,15'-monooxygenase. Naturally occurring primarily as beta-cryptoxanthin (the biologically active epimer). Found in highest concentrations in papaya (~820 mcg/100g), red bell peppers (~490 mcg/100g), tangerines (~407 mcg/100g), persimmons (~1447 mcg/100g), and pumpkin (~1500 mcg/100g). Bioavailability is enhanced by co-consumption with dietary fats (minimum ~3-5g fat recommended); absorption follows micellar solubilization pathway in small intestine. Bioavailability estimated at 3-8% from whole food matrices, improving with food processing/cooking. Transported in plasma primarily via LDL and HDL particles. Plasma concentrations in well-nourished adults typically range 0.1-0.6 mcmol/L. Accumulates preferentially in liver, adipose tissue, and reproductive organs. No established Dietary Reference Intake (DRI) as an isolated compound; contributes to total carotenoid intake goals of approximately 3-6 mg/day carotenoids suggested by some nutrition researchers.
How It Works
Mechanism of Action
Beta-cryptoxanthin quenches singlet oxygen and scavenges peroxyl radicals through its 11-conjugated double bond system, reducing lipid peroxidation of cell membranes. It is cleaved by the enzyme BCMO1 in enterocytes to yield retinaldehyde, which is subsequently reduced to retinol (vitamin A), activating nuclear retinoic acid receptors (RAR and RXR) to regulate gene transcription. Additionally, beta-cryptoxanthin may modulate osteoblast differentiation by upregulating bone morphogenetic protein (BMP) signaling and inhibiting osteoclastogenesis via suppression of RANKL expression.
Clinical Evidence
Epidemiological data from large cohort studies, including the Nurses' Health Study and EPIC cohort involving tens of thousands of participants, associate higher serum beta-cryptoxanthin levels with reduced risk of lung cancer and improved bone mineral density. A cross-sectional analysis of Japanese postmenopausal women (n=～700) found that higher dietary beta-cryptoxanthin intake from Satsuma mandarin oranges correlated with significantly lower osteoporosis risk. However, no large-scale randomized controlled trials (RCTs) have specifically isolated beta-cryptoxanthin supplementation to confirm causal efficacy, making the current evidence largely observational and preliminary. Serum concentrations from dietary studies typically range from 0.1 to 0.5 µmol/L, with intakes of 3–6 mg/day from food sources corresponding to measurable increases in plasma levels.
Safety & Interactions
Beta-cryptoxanthin from food sources is considered safe, and no tolerable upper intake level has been formally established by health authorities given the absence of documented toxicity at dietary levels. Unlike beta-carotene, high-dose supplemental cryptoxanthin has not been associated with the pro-oxidant effects or increased lung cancer risk observed in smokers taking isolated beta-carotene supplements (CARET trial), though caution is still advisable. Cryptoxanthin may theoretically interact with medications that affect lipid absorption, such as orlistat or cholestyramine, which can reduce carotenoid bioavailability by up to 30–40%. Pregnant women should be cautious with high-dose provitamin A supplements in general, as excessive retinol activity during pregnancy carries teratogenic risk, though food-derived cryptoxanthin at normal dietary levels is not a concern.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
β-cryptoxanthinbeta-cryptoxanthincryptoxanthin carotenoidoxygenated carotenoidC₄₀H₅₆O carotenoidorange-yellow carotenoidtetraterpene cryptoxanthin
Frequently Asked Questions
What foods are highest in beta-cryptoxanthin?
Satsuma mandarins and tangerines are among the richest sources, providing approximately 0.5–1.2 mg of beta-cryptoxanthin per 100g. Red bell peppers, papayas, and butternut squash also contribute meaningful amounts, typically 0.1–0.5 mg per 100g serving. Bioavailability is enhanced when these foods are consumed with dietary fat, as cryptoxanthin is a fat-soluble carotenoid requiring micellarization for intestinal absorption.
Is cryptoxanthin the same as vitamin A?
Cryptoxanthin is not vitamin A itself but is classified as a provitamin A carotenoid, meaning the body can convert it into retinol (vitamin A). The enzyme BCMO1 cleaves beta-cryptoxanthin at its central double bond, yielding two molecules of retinaldehyde, though conversion efficiency is lower than that of beta-carotene, estimated at roughly half the activity per microgram. Its retinol activity equivalent (RAE) is approximately 1/24th that of preformed retinol.
Can cryptoxanthin improve bone density?
Observational research suggests an association between higher beta-cryptoxanthin intake and better bone mineral density, particularly in postmenopausal women. A study of Japanese women consuming high amounts of beta-cryptoxanthin-rich Satsuma mandarins showed significantly lower rates of osteoporosis compared to low-intake groups, with proposed mechanisms involving stimulation of osteoblast activity via BMP-2 signaling and suppression of osteoclast formation. However, no RCT has confirmed a direct causal bone-protective effect of isolated cryptoxanthin supplementation as of current evidence.
How much cryptoxanthin should I take per day?
No official recommended dietary allowance (RDA) or established supplemental dosage exists for cryptoxanthin, as it is not classified as an essential nutrient. Dietary intake in populations with high mandarin consumption (e.g., parts of Japan) averages 2–6 mg/day from food, which corresponds to the levels associated with health benefits in observational studies. Supplement doses in commercial products typically range from 1–3 mg, but clinical validation for any specific dose is currently lacking.
Does cryptoxanthin reduce cancer risk?
Epidemiological studies, including large cohort analyses, have found inverse associations between serum beta-cryptoxanthin levels and lung cancer risk, with some data suggesting up to a 30–40% lower risk in the highest versus lowest intake quintiles. The proposed mechanism involves antioxidant quenching of carcinogen-induced ROS and retinoic acid receptor-mediated regulation of cell differentiation and apoptosis. Critically, these are observational associations, and no clinical trial has established that cryptoxanthin supplementation causally reduces cancer incidence in humans.
What is the difference between cryptoxanthin and other carotenoids like lycopene or lutein?
Cryptoxanthin is a xanthophyll carotenoid with a ionone ring structure that allows partial conversion to vitamin A in the body, distinguishing it from non-provitamin carotenoids like lycopene and lutein. While lycopene and lutein primarily function as antioxidants without vitamin A activity, cryptoxanthin's provitamin A capability makes it metabolically similar to beta-carotene but with different food sources and absorption patterns. Each carotenoid has unique tissue distribution and health associations—cryptoxanthin concentrates in bones and may support skeletal health, whereas lutein accumulates in the eye and lycopene in the prostate.
How does fat intake affect cryptoxanthin absorption?
Cryptoxanthin, like all fat-soluble carotenoids, requires dietary fat for optimal absorption in the intestines; consuming it with a meal containing 3–5 grams of fat significantly enhances bioavailability. The type of fat matters—olive oil and other healthy fats support absorption better than minimal-fat meals, making cryptoxanthin-rich foods like oranges most beneficial when paired with fat-containing meals. Malabsorption conditions, bile salt deficiencies, and certain medications that reduce fat digestion can impair cryptoxanthin uptake regardless of dietary intake.
Is cryptoxanthin safe to take with medications for cholesterol or blood thinning?
Cryptoxanthin has no documented direct interactions with statins or anticoagulants like warfarin, though carotenoids theoretically may have mild anticoagulant properties at very high supplemental doses. Individuals taking blood thinners should maintain consistent dietary intake of cryptoxanthin-rich foods rather than introducing large supplemental amounts without medical consultation. Those using cholesterol-lowering medications should be aware that severe fat-malabsorption from certain statins may slightly reduce cryptoxanthin absorption, but this is not a contraindication for use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w cryptoxanthin curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
